• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于神经科和精神科专业服务数据的匈牙利痴呆症流行病学研究。

Dementia epidemiology in Hungary based on data from neurological and psychiatric specialty services.

机构信息

Department of Neurology, Semmelweis University, Budapest Balassa utca 6., Budapest, 1083, Hungary.

MTA-SE Neuroepidemiological Research Group ELKH, Budapest Balassa utca 6., Budapest, 1083, Hungary.

出版信息

Sci Rep. 2021 May 14;11(1):10333. doi: 10.1038/s41598-021-89179-3.

DOI:10.1038/s41598-021-89179-3
PMID:33990624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8121883/
Abstract

Hungary has a single-payer health insurance system covering 10 million inhabitants. All medical reports of the in- and outpatient specialist services were collected in the NEUROHUN database. We used ICD-10 codes of Alzheimer's disease (AD), vascular dementia (VaD), miscellaneous dementia group and mild cognitive impairment (MCI) for the inclusion of the patients. Incidence, prevalence and survival of different dementias and MCI were calculated and analyzed depending on the diagnoses given by neurological or psychiatric services or both. Between 2011 and 2016, the mean crude incidence of all dementias was 242/100,000/year, whereas the age standardized incidence was 287/100,000/year. Crude and age standardized mean prevalence rates were 570/100,000 and 649/100,000, respectively. There were significantly more VaD diagnoses than AD, the VaD:AD ratio was 2.54:1, being the highest in patients with psychiatric diagnoses only (4.85:1) and the lowest in patients with only neurological diagnoses (1.32:1). The median survival after the first diagnosis was 3.01 years regarding all dementia cases. Compared to international estimates, the prevalence of dementia and MCI is considerably lower in Hungary and the VaD:AD ratio is reversed.

摘要

匈牙利拥有覆盖 1000 万居民的单一支付者医疗保险系统。所有门诊和住院专科服务的医疗报告都被收集在 NEUROHUN 数据库中。我们使用阿尔茨海默病(AD)、血管性痴呆(VaD)、其他类型痴呆和轻度认知障碍(MCI)的 ICD-10 编码来纳入患者。根据神经病学或精神病学服务或两者的诊断,计算和分析了不同类型痴呆和 MCI 的发病率、患病率和生存率。在 2011 年至 2016 年期间,所有类型痴呆的平均粗发病率为 242/100,000/年,而年龄标准化发病率为 287/100,000/年。粗发病率和年龄标准化的平均患病率分别为 570/100,000 和 649/100,000。VaD 的诊断明显多于 AD,VaD:AD 比为 2.54:1,在仅接受精神病学诊断的患者中最高(4.85:1),在仅接受神经病学诊断的患者中最低(1.32:1)。首次诊断后,所有痴呆病例的中位生存时间为 3.01 年。与国际估计相比,匈牙利的痴呆症和 MCI 的患病率明显较低,且 VaD:AD 比发生逆转。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/cf0a9de7ea4d/41598_2021_89179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/96b58595d4ea/41598_2021_89179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/98e7c2ed0069/41598_2021_89179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/7a98bcee3fc7/41598_2021_89179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/cf0a9de7ea4d/41598_2021_89179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/96b58595d4ea/41598_2021_89179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/98e7c2ed0069/41598_2021_89179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/7a98bcee3fc7/41598_2021_89179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/697c/8121883/cf0a9de7ea4d/41598_2021_89179_Fig4_HTML.jpg

相似文献

1
Dementia epidemiology in Hungary based on data from neurological and psychiatric specialty services.基于神经科和精神科专业服务数据的匈牙利痴呆症流行病学研究。
Sci Rep. 2021 May 14;11(1):10333. doi: 10.1038/s41598-021-89179-3.
2
Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease?轻度认知障碍是否像阿尔茨海默病那样是血管性痴呆的前驱症状?
Stroke. 2002 Aug;33(8):1981-5. doi: 10.1161/01.str.0000024432.34557.10.
3
Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies.代谢综合征、轻度认知障碍和痴呆:纵向研究的荟萃分析。
Am J Geriatr Psychiatry. 2019 Jun;27(6):625-637. doi: 10.1016/j.jagp.2019.01.214. Epub 2019 Feb 15.
4
The epidemiology of mild cognitive impairment, Alzheimer's disease and related dementia in U.S. veterans.美国退伍军人轻度认知障碍、阿尔茨海默病及相关痴呆的流行病学。
Alzheimers Dement. 2023 Sep;19(9):3977-3984. doi: 10.1002/alz.13071. Epub 2023 Apr 28.
5
[Survey of comorbidities for hospitalized patients with cognitive disorders].[认知障碍住院患者的共病情况调查]
Zhonghua Yi Xue Za Zhi. 2012 Jan 17;92(3):156-9.
6
Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK.英国阿尔茨海默病或血管性痴呆患者的流行病学、合并症和药物使用情况。
J Alzheimers Dis. 2013;35(3):565-73. doi: 10.3233/JAD-121819.
7
Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.阿尔茨海默病、血管性痴呆和混合性痴呆中的动脉粥样硬化、高血压和糖尿病:患病率和表现。
J Alzheimers Dis. 2018;65(4):1247-1258. doi: 10.3233/JAD-180644.
8
Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors.台湾南部痴呆症的发病率及亚型:社会人口学因素的影响
Neurology. 1998 Jun;50(6):1572-9. doi: 10.1212/wnl.50.6.1572.
9
Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease.中年期体力活动与较低的血管性痴呆发病率相关,但与阿尔茨海默病无关。
Alzheimers Res Ther. 2019 Oct 20;11(1):87. doi: 10.1186/s13195-019-0538-4.
10
Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.阿尔茨海默病和非阿尔茨海默病性痴呆中步态障碍的患病率和严重程度。
J Am Geriatr Soc. 2005 Oct;53(10):1681-7. doi: 10.1111/j.1532-5415.2005.53552.x.

引用本文的文献

1
Western Diet and Cognitive Decline: A Hungarian Perspective-Implications for the Design of the Semmelweis Study.西方饮食与认知衰退:匈牙利视角——对塞梅尔维斯研究设计的启示
Nutrients. 2025 Jul 27;17(15):2446. doi: 10.3390/nu17152446.
2
Micro-gyms as a catalyst for healthy aging in university and healthcare settings: applications for the Semmelweis-EUniWell Workplace Health Promotion Model Program.微型健身房作为大学和医疗保健环境中健康老龄化的催化剂:在塞梅尔维斯 - EUniWell工作场所健康促进模式计划中的应用
Geroscience. 2025 Mar 15. doi: 10.1007/s11357-025-01595-9.
3
Developing a Health Support System to Promote Care for the Elderly.

本文引用的文献

1
Biomarkers in the diagnosis and prognosis of Alzheimer's disease.阿尔茨海默病诊断与预后中的生物标志物
J Neurol. 2020 Aug;267(8):2475-2477. doi: 10.1007/s00415-020-10037-9.
2
Dementia is Associated With Poorer Quality of Care and Outcomes After Stroke: An Observational Study.痴呆与中风后护理质量和结局较差相关:一项观察性研究。
J Gerontol A Biol Sci Med Sci. 2021 Apr 30;76(5):851-858. doi: 10.1093/gerona/glaa139.
3
Hospitalizations and Mortality of Individuals with Dementia: Evidence from Czech National Registers.痴呆患者的住院和死亡情况:来自捷克国家登记处的证据。
开发一个促进老年人护理的健康支持系统。
Sensors (Basel). 2025 Jan 14;25(2):455. doi: 10.3390/s25020455.
4
Exploration of the Hungarian Version of Test Your Memory in General Practice: A Cross-Sectional Correlational Study of a Convenience Sample of Middle-Aged and Older Adults.匈牙利语版《在全科医疗中测试你的记忆力》的探索:一项针对中老年成年人便利样本的横断面相关性研究。
Geriatrics (Basel). 2024 Jun 3;9(3):74. doi: 10.3390/geriatrics9030074.
5
Suicide-Related Single Nucleotide Polymorphisms, and : Association with Dementia in Older Adults.与自杀相关的单核苷酸多态性,以及:与老年人痴呆症的关联。
Genes (Basel). 2022 Nov 21;13(11):2174. doi: 10.3390/genes13112174.
6
Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary.胆碱酯酶抑制剂治疗痴呆症:匈牙利的真实数据。
Geroscience. 2022 Feb;44(1):253-263. doi: 10.1007/s11357-021-00470-7. Epub 2021 Oct 15.
J Alzheimers Dis. 2020;75(3):1017-1027. doi: 10.3233/JAD-191117.
4
Differences in cognitive performance and cognitive decline across European regions: a population-based prospective cohort study.欧洲各地区认知表现和认知衰退的差异:一项基于人群的前瞻性队列研究。
Eur Psychiatry. 2019 May;58:80-86. doi: 10.1016/j.eurpsy.2019.03.001. Epub 2019 Mar 12.
5
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家卒中负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 May;18(5):439-458. doi: 10.1016/S1474-4422(19)30034-1. Epub 2019 Mar 11.
6
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家阿尔茨海默病及其他类型痴呆症负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Jan;18(1):88-106. doi: 10.1016/S1474-4422(18)30403-4. Epub 2018 Nov 26.
7
A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.采用 DSM-IV 诊断标准的最高质量研究对欧洲痴呆症患病率的系统评价和荟萃分析。
J Alzheimers Dis. 2018;66(4):1471-1481. doi: 10.3233/JAD-180416.
8
Stroke as a Cause of Death in Death Certificates of Patients with Dementia: A Cohort Study from the Swedish Dementia Registry.中风在痴呆患者死亡证明中作为死因的研究:来自瑞典痴呆症登记处的队列研究。
Curr Alzheimer Res. 2018;15(14):1322-1330. doi: 10.2174/1567205015666181002134155.
9
Dementia subtype and living well: results from the Improving the experience of Dementia and Enhancing Active Life (IDEAL) study.痴呆亚型与生活质量:改善痴呆体验和增强积极生活(IDEAL)研究的结果。
BMC Med. 2018 Sep 11;16(1):140. doi: 10.1186/s12916-018-1135-2.
10
Demand for neurological services in Central Eastern Europe: a 10-year national survey in Hungary.中东欧地区对神经科服务的需求:匈牙利的一项为期 10 年的全国性调查。
Eur J Neurol. 2018 Jul;25(7):984-990. doi: 10.1111/ene.13645. Epub 2018 Apr 18.